HCI's groundbreaking cancer research occurs in many areas - from the lab bench to the clinic to our community and beyond. Scientists pursuing these bold research ideas are engaged in a lifetime of learning that begins with training as a young student and continues throughout their career. As much as anything, training the next generation of cancer researchers is critical to reducing the heavy burden of a cancer diagnosis.

There are a wide variety of undergraduate, pre- and post-doctoral training opportunities available in the laboratories of Huntsman Cancer Institute members. These training opportunities encompass basic science discovery, clinical investigation and population-based studies. Our goals are to understand cancer from its beginnings, to use this knowledge to create new and better treatments, to implement these strategies to improve outcomes and to learn from our efforts across populations to continually minimize the burdens of cancer.

Trainees flourish in a collaborative and collegial, multidisciplinary research environment under the guidance of experienced mentors. 

Recent News

Press Releases, HCI News

Huntsman Cancer Institute applauds the Utah State Legislature for raising the age of sale for tobacco products to 21

Huntsman Cancer Institute (HCI) at the University of Utah applauds the bold actions taken by the Utah State Legislature this week in addressing tobacco-related health issues. The state’s approval of a policy that incrementally increases the age from 19 to 21 for the sale and use of tobacco products, e-cigarettes, and vaping devices—a policy called Tobacco 21—is a step that will ensure Utah remains a national leader in health by reducing tobacco-related illnesses and protecting youth from nicotine addiction.

Read More

Press Releases, HCI News

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.

Read More